长期随访下非诊断性甲状腺结节恶性风险再评估
该回顾性队列研究纳入1269例非诊断性甲状腺结节患者,基于核心针活检或手术切除病理确定恶性风险(ROM)。ROM范围为5.0%至17.7%,12个月随访时ROM上限13.2%与Bethesda系统2023版平均ROM 13%一致;年轻年龄、毛刺边缘和低回声为恶性独立相关因素。
要点
- 非诊断性甲状腺结节ROM范围为5.0%–17.7%,12个月随访上限13.2%与Bethesda系统13%一致。
- 年轻年龄、毛刺边缘和低回声是恶性独立相关因素。
- 核心针活检可作为辅助诊断工具快速明确非诊断性结节性质。
核心结论
- 本研究旨在降低既往仅基于罕见手术随访结果高估的非诊断性甲状腺结节ROM上限。
- 使用核心针活检作为辅助诊断工具有助于快速明确初诊非诊断性甲状腺结节并指导管理。
研究设计与样本
- 回顾性队列研究,纳入Asan Medical Center共10337例接受FNA患者中的1269例非诊断性甲状腺结节患者。
- ROM基于核心针活检或手术切除后的病理结果确定。
- 初始FNA后中位随访时间为14.14个月(范围0.03–145.81个月)。
主要发现
- 361例(28.4%)患者有组织学随访,其中49例(13.6%)仅有手术切除标本,252例(69.8%)仅有CNB标本,60例(16.6%)同时有切除和CNB标本。
- 该队列ROM范围为5.0%至17.7%。
- 本研究12个月随访时ROM上限(13.2%)与2023年更新的Bethesda甲状腺细胞病理学报告系统建议的平均ROM(13%)相同。
- 多因素logistic回归显示,年轻年龄(p = .013)、毛刺边缘(p = .010)和低回声(p = .001)与恶性独立相关。
临床怎么用
- 对于初诊非诊断性甲状腺结节,可考虑使用核心针活检作为辅助诊断工具以快速明确性质。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ultrasound-guided fine-needle aspiration (FNA) of various thyroid nodules often yields nondiagnostic results, which reveal a wide range of the risk of malignancy (ROM) and complicate patient management decisions. This ROM variability likely reflects selection bias, given that previous studies frequently excluded patients without histologic follow-up. METHODS: This retrospective cohort study included 1269 patients with nondiagnostic thyroid nodules from a total of 10,337 patients who underwent FNA at Asan Medical Center. The ROM was determined on the basis of pathologic findings after core needle biopsy (CNB) or resection. RESULTS: The median follow-up period after the initial FNA was 14.14 months (range, 0.03-145.81 months). Histologic follow-up was available for 361 patients (28.4%), with 49 patients (13.6%) having only surgical resection specimens, 252 patients (69.8%) having only CNB specimens, and 60 patients (16.6%) having both resection and CNB specimens. Sixty-four patients were diagnosed with malignancy on the basis of CNB or surgical resection. The ROM in this cohort ranged from 5.0% to 17.7%. The upper limit of the ROM (13.2%) at the 12-month follow-up in this study was the same as the mean ROM (13%) suggested in The Bethesda System for Reporting Thyroid Cytopathology as updated in 2023. Multivariate logistic regression revealed that younger age (p = .013), spiculated margins (p = .010), and hypoechogenicity (p = .001) were independently associated with malignancy. CONCLUSIONS: This study aimed to reduce the overestimated upper limit of the ROM in nondiagnostic thyroid nodules, which was previously based solely on rare surgical follow-up results. Using CNB as an ancillary diagnostic tool can help to rapidly characterize initially nondiagnostic thyroid nodules and guide appropriate management.
引用
- Jeong JS, Choi YJ, Lee JH, et al. Reevaluation of malignancy risk in nondiagnostic thyroid nodules with long-term follow-up via surgical resection or core needle biopsy: A retrospective study. Cancer Cytopathol. 2026. PMID: 41432102. doi:10.1002/cncy.70068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。